Atypical STAT5B deficiency, severe short stature and mild immunodeficiency associated with a novel homozygous STAT5B Variant

Mol Cell Endocrinol. 2023 Jan 1:559:111799. doi: 10.1016/j.mce.2022.111799. Epub 2022 Oct 17.

Abstract

STAT5B deficiency, a rare autosomal recessive disorder characterized by severe growth hormone insensitivity (GHI) and immunodeficiency, can manifest as fatal pulmonary complications. We describe atypical STAT5B deficiency associated with a novel homozygous frame-shift STAT5B variant [c.1453delG, p.(Asp485Thrfs*29)] identified in a young 17.6 yr old female subject who had severe postnatal growth impairment, biochemistries typical of GHI, an immune profile notable for hypergammaglobulinaemia and elevated B lymphocytes, and lack of pulmonary disease. Marked elevation of serum prolactin and pathologically diagnosed eczema were evident. In reconstitution studies, the STAT5B p.(Asp485Thrfs*29) was expressed although expression was reduced compared to wild-type STAT5B and a previously identified STAT5B p.(Gln368Profs*9) variant. Both truncated STAT5B peptides could not be activated by GH, nor mobilize to the nucleus. We conclude that an intact, functional, STAT5B is essential for normal GH-mediated growth, while expressed loss-of-function STAT5B variants may alleviate severe immune and pulmonary issues normally associated with STAT5B deficiency.

Keywords: Growth hormone insensitivity; Immune deficiency; STAT5B.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Dwarfism* / genetics
  • Female
  • Growth Hormone / metabolism
  • Humans
  • Immunologic Deficiency Syndromes* / genetics
  • Insulin-Like Growth Factor I / metabolism
  • STAT5 Transcription Factor / genetics
  • STAT5 Transcription Factor / metabolism

Substances

  • Insulin-Like Growth Factor I
  • STAT5 Transcription Factor
  • Growth Hormone
  • STAT5B protein, human